Search
Hidradenitis Suppurativa (HS) Clinical Trials
A listing of 3 Hidradenitis Suppurativa (HS) clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
There are currently 3 active clinical trials seeking participants for Hidradenitis Suppurativa (HS) research studies. The states with the highest number of trials for Autism participants are Florida, Ontario, California and Massachusetts.
Featured Trial
Hidradenitis Suppurativa (HS) Study Now Enrolling
Recruiting
See if you qualify to help potentially advance the way hidradentisis suppurativa is treated. Enroll Now! Travel Expenses Reimbursed.
Conditions:
Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Hidradenitis
Suppurative Hidradenitis
Acne Inversa
* Compensation for time may be available
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Recruiting
The purpose of this study is to evaluate the efficacy and safety of Povorcitinib (INCB054707) in participants with moderate to severe Hidradenitis Suppurativa (HS) over a 12-week placebo controlled period, followed by a 42-week extension period.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: Investigative Site US303, Phoenix, Arizona +90 locations
Conditions: Hidradenitis Suppurativa (HS)
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of Povorcitinib (INCB054707) in participants with moderate to severe Hidradenitis Suppurativa (HS) over a 12-week placebo-controlled period, followed by a 42-week extension period.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: Investigative Site US240, Scottsdale, Arizona +102 locations
Conditions: Hidradenitis Suppurativa (HS)
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Recruiting
The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 [NCT05620823] or INCB 54707-302 [NCT05620836]).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: Investigative Site US303, Phoenix, Arizona +175 locations
Conditions: Hidradenitis Suppurativa (HS)
1 - 3 of 3